Peptides: NHS vs Private Access in the UK
By Dr David Chen, PharmD · Reviewed by the Editorial Board
Some peptides are available through the NHS whilst others require private prescriptions. This guide compares access routes, costs and what to expect from each pathway.
Table of Contents (5 sections)
What's Available on the NHS
Several peptide-based medications are available through the NHS, though eligibility criteria apply.
GLP-1 agonists for type 2 diabetes: - Liraglutide (Victoza), Semaglutide injection (Ozempic), Semaglutide oral (Rybelsus), Tirzepatide (Mounjaro), Dulaglutide (Trulicity)
GLP-1 agonists for weight management: - Semaglutide 2.4mg (Wegovy): NICE-approved with BMI ≥35 (or ≥30 with weight-related comorbidity) through specialist weight management services - Tirzepatide (Mounjaro for weight): Under NICE appraisal for obesity indication
Other peptide-based NHS medications: - Insulin (various forms), Teriparatide (Forteo) for severe osteoporosis, Octreotide for acromegaly, Goserelin (Zoladex) for prostate cancer
What's NOT available on the NHS: BPC-157, TB-500, CJC-1295, ipamorelin, epitalon, GHK-Cu, melanotan-II — none of these are licensed medicines in the UK
NHS Access: The Practical Reality
Getting peptide-based treatments through the NHS involves specific pathways and criteria.
Wegovy (semaglutide for weight loss) — NHS pathway: 1. BMI must be ≥35 (or ≥30 with a weight-related comorbidity) 2. Referral to specialist weight management service (Tier 3) 3. Requires demonstrating that lifestyle interventions have been attempted 4. Waiting times: 6 months to 2+ years depending on area 5. Treatment typically for a maximum of 2 years under NICE guidance
GLP-1 agonists for diabetes: 1. Usually prescribed after metformin and other oral medications have been tried 2. Prescribed by GP or diabetes specialist 3. Generally more accessible than weight management prescriptions
Common frustrations: - Long waiting times for specialist services - "Postcode lottery" in availability - Supply shortages affecting Wegovy and Ozempic - Strict eligibility criteria
Tips for navigating NHS access: - Ask your GP specifically about GLP-1 eligibility - Request Tier 3 referral early — waiting lists are long - Keep records of lifestyle interventions attempted
Private Clinic Access
Private clinics offer faster access and wider range, but at significantly higher cost.
GLP-1 agonists (weight management): - Semaglutide (Wegovy): £150–£300/month - Tirzepatide (Mounjaro): £150–£350/month - Lower eligibility thresholds than NHS - Online consultations and home delivery available - No waiting lists
Telehealth / online prescribing services: - Services like Manual, Numan and specialist weight loss clinics offer remote consultations - Quality varies — some provide excellent oversight; others are essentially dispensaries
Functional medicine / integrative clinics: - May prescribe or supervise GH secretagogues, BPC-157 and other research peptides - Consultation fees: £150–£400 plus medication costs - Operate in a regulatory grey area for non-licensed peptides - CQC registration and practitioner qualifications vary
Anti-ageing and aesthetics clinics: - Topical peptide treatments (GHK-Cu, matrixyl) as part of skincare packages - £100–£500 per treatment session
Cost Comparison: NHS vs Private
GLP-1 agonists — the clearest comparison:
- •NHS Wegovy: Free (prescription charge £9.90) | Wait: 6 months–2+ years | BMI ≥35 required
- •Private Wegovy: £150–£300/month | Wait: days | BMI ≥27–30 (varies)
- •NHS annual cost: £118.80 (prepayment certificate)
- •Private annual cost: £1,800–£4,200
When NHS makes sense: - You meet eligibility criteria and can wait - Cost is a primary concern - You value the multidisciplinary team approach
When private makes sense: - You don't meet NHS eligibility criteria - You can't wait 6+ months - You prefer telehealth convenience
Important note on private prescribing quality: Not all private clinics are equal. The best provide thorough clinical assessment and regular monitoring. The worst are essentially prescription mills with minimal clinical engagement. Price alone doesn't indicate quality.
Making the Right Choice
Decision framework:
Step 1: Determine what you need - Approved medication for a medical condition? → NHS or private prescription - Research peptides for recovery or anti-ageing? → Private clinic or self-directed (with risks) - Topical peptides for skin? → Over-the-counter; no prescription needed
Step 2: Check NHS eligibility first - Your GP can clarify eligibility in a single appointment - If eligible, get on the waiting list even if you start privately — you can switch later
Step 3: If going private, verify the provider - Check CQC registration (cqc.org.uk) - Verify prescriber qualifications (GMC registration for doctors) - Look for clinics requiring blood work before prescribing - Read independent reviews
Step 4: Consider long-term cost - GLP-1 agonists may be needed long-term; private costs accumulate - Factor in blood work, consultations and dose escalation
Red flags (private clinics): - Prescribing without clinical assessment - No ongoing monitoring - Making unsupported treatment claims - No clear complaints procedure
*This guide is for educational purposes only. Consult your GP for personalised medical advice regarding peptide-based treatments.*
Related Peptide Profiles
Related Research Guides
Related Comparisons
Related Articles
How to Get Peptides Prescribed in the UK: A Practical Guide
A practical walkthrough of every route to obtaining peptide medications in the UK — from NHS prescriptions and private clinics to the legal status of research-only compounds.
10 min readNHS Peptide Prescriptions: What You Can Get and How
A realistic guide to obtaining peptide-based medications through the NHS — from NICE-approved GLP-1 agonists and weight management pathways to specialist hormone therapies and what to expect at each stage.
10 min readWeight Loss Injections Without Prescription UK: Risks & Safer Options
Thousands of UK adults buy weight loss injections without prescriptions. Here's why it's risky, what the law says, and safer ways to access these medications.
10 min readPeptides and the NHS: What Your GP Needs to Know
Navigating peptide use within the NHS requires understanding what GPs can prescribe, how to have productive conversations about monitoring, and when disclosing unlicensed peptide use is in your best interest.
8 min readDiscuss This Article
Join the UK's leading peptide research community — ask questions, share experiences, and learn from fellow researchers.